SATL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.084000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.410170E-01
Normal-vs-Stage2
6.724400E-01
Normal-vs-Stage3
6.762200E-01
Normal-vs-Stage4
3.108000E-01
Stage1-vs-Stage2
8.298300E-02
Stage1-vs-Stage3
6.125900E-02
Stage1-vs-Stage4
2.836800E-01
Stage2-vs-Stage3
2.970800E-01
Stage2-vs-Stage4
7.061000E-01
Stage3-vs-Stage4
1.916370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.664600E-01
Normal-vs-AfricanAmerican
3.093600E-01
Normal-vs-Asian
7.694200E-01
Caucasian-vs-AfricanAmerican
6.290800E-01
Caucasian-vs-Asian
7.993600E-02
AfricanAmerican-vs-Asian
1.862850E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.301600E-01
Normal-vs-Female
5.919600E-01
Male-vs-Female
5.972800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.303400E-01
Normal-vs-Age(41-60Yrs)
2.955800E-01
Normal-vs-Age(61-80Yrs)
8.222600E-01
Normal-vs-Age(81-100Yrs)
8.956200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.591800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.051020E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.551800E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.897100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.795400E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.701800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.713600E-01
Normal-vs-Daily Drinker
6.036200E-01
Normal-vs-Weekly Drinker
6.459600E-01
Normal-vs-Occasional Drinker
4.799800E-01
Normal-vs-Social Drinker
3.557600E-01
Non Drinker-vs-Daily Drinker
6.240800E-01
Non Drinker-vs-Weekly Drinker
8.907600E-01
Non Drinker-vs-Occasional Drinker
6.050400E-01
Non Drinker-vs-Social Drinker
1.849990E-01
Daily Drinker-vs-Weekly Drinker
7.805000E-01
Daily Drinker-vs-Occasional Drinker
9.334200E-01
Daily Drinker-vs-Social Drinker
4.176200E-01
Weekly Drinker-vs-Occasional Drinker
7.995200E-01
Weekly Drinker-vs-Social Drinker
2.941800E-01
Occasional Drinker-vs-Social Drinker
3.186800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.918400E-01
Normal-vs-Grade 2
9.115600E-01
Normal-vs-Grade 3
8.506000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.353600E-01
Grade 1-vs-Grade 3
5.928400E-01
Grade 1-vs-Grade 4
5.918400E-01
Grade 2-vs-Grade 3
3.074600E-01
Grade 2-vs-Grade 4
9.115600E-01
Grade 3-vs-Grade 4
8.506000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.918400E-01
Normal-vs-NonDiabetic
5.303000E-01
Diabetic-vs-NonDiabetic
9.228100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.607200E-01
Normal-vs-NoPancreatitis
6.280800E-01
Pancreatitis-vs-NoPancreatitis
8.004800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.490200E-01
Normal-vs-N1
6.840400E-01
N0-vs-N1
4.469800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.409000E-01
Normal-vs-TP53-NonMutant
2.958000E-01
TP53-Mutant-vs-TP53-NonMutant
1.690010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
